LI Hongda, WU Hualong, WU Shuangshi, ZHAO Jiwei, SUN Hao, HU Le, WANG Yongxiang. Research on screening of serum differential proteins in patients with osteoporosis by iTRAQ technology[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 97-101. DOI: 10.7619/jcmp.202021028
Citation: LI Hongda, WU Hualong, WU Shuangshi, ZHAO Jiwei, SUN Hao, HU Le, WANG Yongxiang. Research on screening of serum differential proteins in patients with osteoporosis by iTRAQ technology[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 97-101. DOI: 10.7619/jcmp.202021028

Research on screening of serum differential proteins in patients with osteoporosis by iTRAQ technology

More Information
  • Received Date: October 11, 2020
  • Available Online: December 21, 2020
  • Published Date: November 23, 2020
  • Objective To analyze the quantitative results of serum differential proteins in osteoporosis patients and healthy people by isobaric tag for relative absolute quantitation(iTRAQ)technology, and to screen and identify the specific serum protein markers for early diagnosis of osteoporosis. Methods Totally 24 serum samples from healthy people and 24 serum samples from senile patients with osteoporosis were collected. The quantitative and qualitative analysis of protein was carried out in each group by iTRAQ technology, and the differences of proteomics in each group were compared. The specific proteins with significant difference(difference multiple>1.2, P<0.01)were screened. By consulting uniport database and related literatures, the characteristics of specific proteins and their correlations with osteoporosis were analyzed to preliminarily identify specific serum protein markers for early diagnosis of osteoporosis. Results A total of 31 osteoporosis-related differential proteins were screened by iTRAQ technology, of which 8 proteins were up-regulated and 23 proteins were down-regulated. EphA4, keratin(KRT)and osteoclast stimulating factor 1(OSTF1)were selected as potential biomarkers of osteoporosis. Conclusion According to the results of ingenuity pathway analysis(IPA)and the biological and physiological functions of each differential protein, three differential proteins of EphA4, KRT and OSTF1 are further screened and identified as potential protein markers for early diagnosis of osteoporosis.
  • DATTA A, QIAN J R, CHONG R F, et al. Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia[J]. J Proteomics, 2014, 99: 54-67.
    VARGAS L M, LEAL N, ESTRADA L D, et al. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers[J]. PLoS One, 2014, 9(3): e92309.
    JING X F, SONOKI T, MIYAJIMA M, et al. EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal[J]. Cancer Med, 2016, 5(6): 1214-1227.
    GUO X L, HU J, LUO W G, et al. Analysis of sera of recipients with allograft rejection indicates that keratin 1 is the target of anti-endothelial antibodies[J]. J Immunol Res, 2017, 2017: 8679841.
    LUO W G, ZHOU B, LUO Q Z, et al. Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population[J]. PLoS One, 2017, 12(10): e0186409.
    LYRAKI R, LOKAJ M, SOARES D C, et al. Characterization of a novel RP2-OSTF1 interaction and its implication for actin remodelling[J]. J Cell Sci, 2018, 131(4): jcs211748.
    VINAYAGAM A, STELZL U, FOULLE R, et al. A directed protein interaction network for investigating intracellular signal transduction[J]. Sci Signal, 2011, 4(189): rs8.
    SULAIMAN R S, KADMIEL M, CIDLOWSKI J A. Glucocorticoid receptor signaling in the eye[J]. Steroids, 2018, 133: 60-66.
    VERMEREN M, LYRAKI R, WANI S, et al. Osteoclast stimulation factor 1(OSTF1)knockout increases trabecular bone mass in mice[J]. Mamm Genome, 2017, 28(11/12): 498-514.
  • Related Articles

    [1]XU Xinlong, LI Huan, MA Kaixuan. Correlations of the expression of silencing information regulatory factor 2-related enzyme-1 and colony-stimulating factor 1 receptors with clinical features and prognosis in patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 70-74. DOI: 10.7619/jcmp.20242568
    [2]WANG Yu, YANG Jixue, GUO Dianqu, LIU Wenbin. Relationships of expression of high mobility group box 1 protein and toll-like receptor 4 in patients with clinical characteristics of refractory epilepsy and their predictive value[J]. Journal of Clinical Medicine in Practice, 2024, 28(19): 68-72, 83. DOI: 10.7619/jcmp.20241965
    [3]XU Wenjuan, WANG Huimin, PENG Juan'e, HUANG Qian, CHEN Li, CAI Liesong. Expression levels of serum microRNA-1-3p and activating transcription factor 4 in elderly patients with chronic heart failure and their relationships with cognitive impairment[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 59-63. DOI: 10.7619/jcmp.20240651
    [4]ZHANG Jing, MAO Ying. Value of combined assessment of serum transforming growth factor-β1, interleukin-6, toll-like receptor-4, and nuclear factor-κb in evaluating the severity of radiation pneumonitis in non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 12-17. DOI: 10.7619/jcmp.20234065
    [5]QIN Yilu, BIAN Caiyue, ZUO Shufei, WU Jie, LIANG Shu, XU Zhendan, FAN Wenqiang. Effect of microRNA-106a-5p/colony stimulating factor 1 axis on immunoglobulin G induced podocyte injury in patients with lupus nephritis[J]. Journal of Clinical Medicine in Practice, 2023, 27(20): 48-53, 58. DOI: 10.7619/jcmp.20231527
    [6]LI Haiyang, ZHANG Miao, LU Feng, DAI Suhua, LI Fangfang, YU Hongliang, HOU Bo, ZHANG Wei, ZHANG Minglei, YIN Xiaodong. Effect of eukaryotic translation initiation factor 4γ2 on the malignant phenotype of gastric cancer cells regulated by N-acetylgalactosaminotransferase 1 mRNA[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 40-49. DOI: 10.7619/jcmp.20222898
    [7]JIN Qianqian, LI Huajun, WANG Xiaoyun, WANG Yuansong, DONG Yanfang, KONG Wubao, SUN Yunchuan, ZHAO Hongmin, NIU Yuelong. Expression of significance of serum secreted frizzled-related protein-4, lipoxygenase A4 and chemerin in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 41-45, 64. DOI: 10.7619/jcmp.20221844
    [8]HUANG Yanyan, LIN Shudian, ZHAN Feng, XIAO Lu, ZHAN Yuwei, MO Biyao, HAN Yeguang. Relationships of expressions of soluble programmed death receptor-1 and interferon regulatory factor 4 with disease activity and immunoinflammation of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 118-121, 137. DOI: 10.7619/jcmp.20214386
    [9]LI Zhenzhen, CHEN Feiren, WU Hongfa, ZHONG Youqing. Influence of propofol on expressions of Toll-like receptor 4 and high mobility group box 1 in the rat model of myocardial ischemia reperfusion injury[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 13-18. DOI: 10.7619/jcmp.20201602
    [10]LONG Quan, ZHU Chun, ZOU Jun, LIU Xiuying, JIANG Gengru. Expression of Toll-like receptor 4 and level of inflammation cytokine IL-6 and chemokine MCP-1 in peripheral blood mononuclear cells of patients with IgA nephropathy[J]. Journal of Clinical Medicine in Practice, 2016, (19): 23-27. DOI: 10.7619/jcmp.201619007
  • Cited by

    Periodical cited type(4)

    1. 俞正勇,曹德茂,齐文涛,王小洪,段晓春. 眶上外侧入路治疗急性期破裂大脑中动脉动脉瘤的经验体会. 实用临床医药杂志. 2022(06): 18-22 . 本站查看
    2. 胡海斌. 动脉瘤夹闭术后脑脊液引流与直接缝合硬脑膜对脑积水及脑血管痉挛风险的影响. 中外医学研究. 2019(04): 1-3 .
    3. 计跃,裴本根,张健,张玉华,尹玮,夏雪,孙志翔,杨奎,孙克. 腰大池持续引流在动脉瘤性蛛网膜下腔出血血管内栓塞术后的治疗作用. 安徽医学. 2018(10): 1259-1261 .
    4. 卢国旺. 腰大池持续脑脊液引流术治疗颅脑损伤术后脑脊液漏的临床研究. 中国医学工程. 2017(08): 70-72 .

    Other cited types(1)

Catalog

    Article views (219) PDF downloads (10) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return